Farms.com Home   News

AFBF: EPA Greenhouse Gas Plan Harmful to Economy, Agriculture

The Environmental Protection Agency's latest greenhouse gas proposal will harm the nation's economy, rural communities and America's farm and ranch families if implemented, the American Farm Bureau Federation says.

The EPA's attempt to impose a 30-percent reduction in carbon dioxide on the nation's power plants will lead to higher energy prices. Farmers would face not just higher prices for electricity, but any energy-related input such as fertilizer. Rural electric cooperatives that rely on old coal plants for cheap electricity would be especially hard hit.

"U.S. agriculture will pay more for energy and fertilizer under this plan, but the harm won't stop there," American Farm Bureau Federation President Bob Stallman said. "Effects will especially hit home in rural America."

Today's announcement follows EPA's April "Waters of the Unites States" proposal that would unlawfully increase the agency's role in regulating America's farms under the Clean Water Act. AFBF responded with a formal campaign to "Ditch the Rule."

 
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.